Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over (original) (raw)

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

1. Williamson DA, Bray GA, Ryan DH. Is 5% weight loss a satisfactory criterion to define clinically significant weight loss? Obesity (Silver Spring). 2015 Dec;23(12):2319–20.
   Article Google Scholar
2. •• Jensen MD, Ryan DH, Donato KA, et al. Guidelines (2013) for managing overweight and obesity in adults. Obesity. 2014;22:S1–S410. These guidelines are based on a systematic evidence review around 5 critical questions (benefits of weight loss, risks of excess body weight, best diet for weight loss, weight loss with comprehensive lifestyle intervention, and role of bariatric surgery)
   Article Google Scholar
3. U.S. Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research (CDER). Guidance for Industry Developing Products for Weight Management. Draft Guidance. 2007. Revision 1. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071612.pdf. Accessed 7 Jan 2017.
4. Diabetes Prevention Program Research Group. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
   Article PubMed Central Google Scholar
5. Tuomilheto J, Lindström J, Eriksson JG, for the Finnish Diabetes Prevention Study Group, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.
   Article Google Scholar
6. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102–7.
   Article PubMed PubMed Central Google Scholar
7. Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481–6.
   Article CAS PubMed PubMed Central Google Scholar
8. Unick JL, Beavers D, Jakicic JM, Kitabchi AE, Knowler WC, Wadden TA, Wing RR, The Look AHEAD Research Group. Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes. Diabetes Care. 2011;34:2152–7.
   Article PubMed PubMed Central Google Scholar
9. Foster GD, Borradaile KE, Sanders MH, Millman R, Zammit G, Newman AB, Wadden TA, Kelley D, Wing RR, Pi-Sunyer FX, Reboussin D, Kuna ST, the Sleep AHEAD Research Group of the Look AHEAD Research Group. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med. 2009;169(17):1619–26.
   Article PubMed PubMed Central Google Scholar
10. Kuna ST, Reboussin DM, Borradaile KE, Sanders MH, Millman RP, Zammit G, Newman AB, Wadden TA, Jakicic JM, Wing RR, Pi-Sunyer FX, Foster GD, Sleep AHEAD Research Group. Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes. Sleep. 2013;36(5):641–9.
    PubMed PubMed Central Google Scholar
11. Messier SP, Loeser RF, Miller GD, Morgan TM, Rejeski WJ, Sevick MA, Ettinger WH, Pahor M, Williamson JD. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis. The Arthritis, Diet, and Activity Promotion Trial. Arthritis & Rheumatism. 2004;50(5):1501–10.
    Article Google Scholar
12. Messier SP, Gutekunst DJ, Davis C, DeVita P. Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis. Arthritis & Rheumatism. 2004;52(7):2026–32.
    Article Google Scholar
13. Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, Beavers DP, Hunter DJ, Lyles MF, Eckstein F, Williamson JD, Carr JJ, Guermazi A, Loeser RF. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013;310(12):1263–73.
    Article CAS PubMed PubMed Central Google Scholar
14. • Hunter DJ, Beavers DP, Ekstein F, Guermazi A, Loeser RF, Nicklas BJ, Mihalko SL, Miller GD, Lyles M, DeVita P, Legault C, Carr JJ, Williamson JD, Messier SP. The Intensive Diet and Exercise for Arthritis (IDEA) trial: 18-month radiographic and MRI outcomes. Osteoarthr Cartil. 2015;23:1090–8. This paper demonstrates that despite significant weight loss and improvements in symptoms and function, there are no changes in MRI or x-ray changes with knee osteoarthritis
    Article CAS PubMed Google Scholar
15. • White DK, Neogi T, Rejeski WJ, Walkup MP, Lewis CE, Nevitt MC, Foy CG, Felson DT, ARG L. Can an intensive diet and exercise program prevent knee pain among overweight adults at high risk? Arthritis Care Res (Hoboken). 2015;67(7):965–71. This paper demonstrates that a lifestyle intervention producing moderate weight loss (5–10%), compared to a control condition, was associated with a reduction in emergence of knee pain over 1 year in persons with obesity and type 2 diabetes. However, over the next 3 years with 50% of the lost weight being regained, there was no difference in emergent rates of knee pain among study groups
    Article Google Scholar
16. Lazo M, Solga S, Horska A, et al., the Fatty Liver Subgroup of the Look AHEAD Research Group. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care. 2010;33(10):2156–63.
17. Promrat K, Kleiner DE, Niemeier HM, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010;51(1):121–9.
    Article CAS PubMed PubMed Central Google Scholar
18. Kolotkin RL, Crosby RD, Williams GR, Hartley GG, Nicol S. The relationship between health-related quality of life and weight loss. Obes Res. 2001 Sep;9(9):564–71.
    Article CAS PubMed Google Scholar
19. Faulconbridge L, Wadden T, Rubin R, the Look AHEAD Research Group, et al. One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study. Obesity. 2012;20(4):783–93.
    Article PubMed Google Scholar
20. Rejeski WJ, Ip EH, Bertoni AG, et al. Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med. 2012;366:1209–17.
    Article CAS PubMed PubMed Central Google Scholar
21. Phelan S, Kanaya AM, Subak LL, et al. Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial. J Urol. 2012;187:939–44.
    Article PubMed PubMed Central Google Scholar
22. Breyer BN, Phelan S, Hogan PE, The Look AHEAD Research Group, et al. Intensive lifestyle intervention reduces urinary incontinence in overweight/obese men with type 2 diabetes: results from the Look AHEAD trial. J Urol 2014
23. Wing R, Rosen R, Fava J, Bahnson J, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. Journal of Sexual Medicine. 2010;7(1 Pt 1):156–65.
    Article PubMed Google Scholar
24. Wing RR, Bond DS, Gendrano IN, The Sexual Dysfunction Subgroup of the Look AHEAD Research Group, et al. Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study. Diab Care. 2013;36:2937–44.
    Article Google Scholar
25. Kiddy DS, Hamilton-Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol. 1992;36:105.
    Article CAS Google Scholar
26. Crosignani PG, Colombo M, Vegetti W, et al. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod. 2003;18:1928.
    Article PubMed Google Scholar
27. Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab. 1999;84:1470.
    CAS PubMed Google Scholar
28. • Look AHEAD Research Group. Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with Type 2 diabetes. Diabetes Care. 2014;37(9):2548–56. This paper shows that modest weight loss (mean 8.7% weight loss at 1 year, with regain of 50% over the next 3 years) was associated with a reduction in costs for hospitalization and in medication costs, but not outpatient medical care costs
    Article Google Scholar
29. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.
    Article PubMed Google Scholar
30. The Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. New Engl J Med. 2013;369(2):145–54.
    Article PubMed Central Google Scholar
31. • Look AHEAD Research Group, Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, Coday M, Curtis JM, Egan C, Evans M, Foreyt J, Foster G, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jeffery RW, Johnson KC, Kitabchi AE, Knowler WC, Kriska A, Lang W, Lewis CE, Montez MG, Nathan DM, Neiberg RH, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Regensteiner J, Rejeski J, Ribisl PM, Safford M, Stewart K, Trence D, Wadden TA, Wing RR, Yanovski SZ. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4(11):913–21. For patients who lost 10% or more in the first year of the study, there was a reduction in major cardiovascular events
    Article Google Scholar
32. Messier RP, Gutekunst DJ, Davis C, DeVita P. Arthritis & rheumatism. 2005;52(7):2026–32.
    Article Google Scholar
33. Sikaris KA. The clinical biochemistry of obesity. Clin Biochem Rev. 2004 Aug;25(3):165–81.
    PubMed PubMed Central Google Scholar
34. Bays H. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr Opin Endocrinol Diabetes Obes. 2014;21(5):345–51.
    Article CAS PubMed PubMed Central Google Scholar
35. •• Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly SC, de las Fuentes K, Sonbing H, Okunade AL, Patterson BW, Klein S. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016;23:1–11. This paper measures advanced clinical endpoints and performs measurements at baseline, after 5% weight loss, after 11% weight loss, and after 16% weight loss and compares to a control, stable-weight condition. It provides insight into the mechanisms by which weight reduction produces effects on different tissues
    Article Google Scholar
36. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. http://www.cdc.gov/arthritis/resources/spotlights/kneereplacements.htm.
37. Williamson D, Rejeski J, Lang W, and the Look AHEAD Research Group, et al. Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med. 2009;169(2):163–71.
    Article PubMed PubMed Central Google Scholar
38. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
    Article CAS PubMed Google Scholar
39. Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med. 2011;29:507.
    Article PubMed Google Scholar
40. •• Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R, reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity—Executive Summary. Endocr Pract. 2016;22(7):842–84. New guidelines from the AACE organization emphasize complications-centric, rather than BMI-centric treatment decisions for patients with overweight and obesity
    Article PubMed Google Scholar
41. http://www.acog.org/About-ACOG/ACOG-Departments/Toolkits-for-Health-Care-Providers/Obesity-Toolkit. Accessed 22 Feb 2017.

Download references